If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
115.00    -1.00 (-0.86%)
Bid:
114.00
Ask:
116.00
Spread: 2.00 (1.754%)
Market Cap: £254.20m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

ERII Compulsory Redemption Announcement

13 Aug 2013 07:00

RNS Number : 5122L
Real Estate Credit Inv. PCC Ltd
13 August 2013
 



NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

 

13 August 2013

REAL ESTATE CREDIT INVESTMENTS PCC LIMITED

RETURN OF CAPITAL TO CELL SHAREHOLDERS

 

In accordance with the powers granted to the Directors under the Cell's articles of association, the Directors announce that they intend to implement a distribution to Cell shareholders of the cash proceeds from the recent realisation of the Cell's assets by way of a compulsory share redemption of Cell shares (the "Redemption").This distribution means no separate dividend for ERII will be declared for the quarter ended 30 June 2013.

 

Redemption of Cell shares

 

The Cell today announces that approximately 17 per cent. of the Cell's issued share capital will be redeemed at close of business on 2 September 2013 (the "Redemption Date") by way of a compulsory redemption of Cell shares by reference to the unaudited quarterly NAV of the Company as at 30 June 2013.

 

The Redemption will be effected pro rata to holdings of Cell shares on the register at the close of business on the Redemption Date (which is the record date for the purposes of the Redemption), being 2 September 2013. The aggregate payment made to Cell shareholders will be €2,410,812 (equivalent to €0.13 per each of the 18,544,711 current outstanding Cell shares).

 

Fractions of Cell shares will not be redeemed and so the number of Cell shares to be redeemed for each Cell shareholder will be rounded down to the nearest whole number of Cell shares. The amount to be applied to the partial redemption of the Cell shares comprises the monies from the realisation of the Cell's assets to be received up to and including 2 September 2013, less the costs and expenses of the Redemption.

 

As at today's date, the Cell has 18,544,711 Cell shares in issue of which none are held in treasury. All of the shares redeemed on the Redemption Date will be cancelled.

 

Settlement

 

In the case of Cell shares held in uncertificated form (that is, in CREST), redemptions will take effect automatically on the Redemption Date and redeemed Cell shares will be cancelled. All Cell shares in issue will be disabled in CREST on the Redemption Date and the existing ISIN applicable to such Cell shares (the "Old ISIN") (which, for the redemption, is GG00B93M1Y64) will expire. A new ISIN (the "New ISIN") in respect of the Cell shares in issue and which have not been redeemed will be enabled and available for transactions from and including the first Business Day following the relevant Redemption Date (or such other date notified to Shareholders). The New ISIN will be GG00BCZQ7837. Up to and including the Redemption Date, Cell shares will be traded under the Old ISIN and, as such, a purchaser of such Cell shares would have a market claim for a proportion of the redemption proceeds. CREST will automatically transform any open transactions as at the Redemption Date (which is the record date for the purposes of the redemption) into the New ISIN.

 

For every 1,000 shares held in the Old ISIN, 830 will be issued in the New ISIN.

 

 

In the case of Cell shares held in certificated form (that is, not in CREST), redemptions will take effect automatically on each Redemption Date. As the Cell shares will be compulsorily redeemed, certificated shareholders do not need to return their Cell share certificates to the Company in order to claim their redemption monies. Shareholders' existing share certificates will be cancelled and new share certificates will be issued to each such shareholder for the balance of their shareholding after each Redemption Date. Cheques will automatically be issued to certificated shareholders upon the cancellation of any of their Cell shares. All Cell shares that are redeemed will be cancelled with effect from the relevant Redemption Date. Accordingly, once redeemed, Cell shares will be incapable of transfer.

 

Payments of redemption monies are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) within 14 Business Days of the relevant Redemption Date, or as soon as practicable thereafter. Shareholders will be paid their redemption proceeds in the currency in which their Cell shares are denominated or as determined by the Directors.

 

-ENDS-

 

For further information:

 

Public Relations:

 

Henrietta Dehn +44 (0)20 7318 5770

 

Investor Relations:

Nicole Von Westenholz +44(0)20 7968 7482

 

Liberum Capital Limited

 

Richard Bootle +44(0)20 3100 2000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALPAFAXDEFF
Date   Source Headline
20th Mar 20251:32 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNSFact Sheet Announcement
14th Mar 20254:34 pmRNSDirector/PDMR Shareholding
19th Feb 20252:59 pmRNSDividend Declaration
14th Feb 20257:00 amRNSFact Sheet Announcement
22nd Jan 20257:00 amRNSFact Sheet Announcement
20th Dec 20242:06 pmRNSDirector/PDMR Shareholding
17th Dec 20243:13 pmRNSFact Sheet Announcement
28th Nov 20243:04 pmRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSDividend Declaration
28th Nov 20247:00 amRNSHalf-year Report
12th Nov 20247:00 amRNSFact Sheet Announcement
5th Nov 20247:00 amRNSDirector Appointment
28th Oct 20247:00 amRNSShare Buyback Programme in a Closed Period
15th Oct 20247:00 amRNSFact Sheet Announcement
10th Oct 20242:25 pmRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSFact Sheet Announcement
30th Sep 20243:30 pmRNSBoard Succession Update
27th Sep 20247:00 amRNSFurther Buyback Programme
25th Sep 20244:43 pmRNSHolding(s) in Company
18th Sep 20244:30 pmRNSDividend Declaration
18th Sep 20243:59 pmRNSResult of AGM and Directorate Change
10th Sep 20247:01 amRNSFact Sheet Announcement
10th Sep 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20244:56 pmRNSHolding(s) in Company
16th Aug 20245:10 pmRNSHolding(s) in Company
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20249:11 amRNSHolding(s) in Company
13th Aug 20247:00 amRNSFact Sheet Announcement
12th Aug 20247:00 amRNSNotice of AGM
9th Aug 20243:00 pmRNSHolding(s) in Company
5th Aug 20245:00 pmRNSHolding(s) in Company
16th Jul 20242:11 pmRNSNew Transaction
9th Jul 20247:00 amRNSFact Sheet Announcement
20th Jun 20247:00 amRNSDividend Declaration
20th Jun 20247:00 amRNSAnnual Financial Report
18th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 202412:30 pmRNSBoard Changes
11th Jun 20245:08 pmRNSHolding(s) in Company
10th Jun 20247:00 amRNSFact Sheet Announcement
28th May 20249:19 amRNSDirector Declaration
21st May 20244:00 pmRNSShare Buyback Programme in a Closed Period
15th May 20244:06 pmRNSHolding(s) in Company
13th May 20247:00 amRNSFact Sheet Announcement
8th May 20247:00 amRNSDirector Appointment
2nd May 20247:00 amRNSNotice of RECI Investor Day
25th Apr 20242:30 pmRNSHolding(s) in Company
16th Apr 202411:56 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.